Get startedLog in
    Picture of KMPharmaceutical Co logo

    225430 — KMPharmaceutical Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    Consumer DefensivesAdventurousMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for KMPharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line471-220-3,925-1,320-4,573
    Depreciation
    Amortisation
    Non-Cash Items2581,3653,1035982,555
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-907-248-645884-1,270
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities9092,267-93.31,446-2,036
    Capital Expenditures-3,737-2,365-10-113-369
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items807-5,693-5,081-5.89-16.8
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-2,930-8,058-5,091-119-386
    Financing Cash Flow Items18510-860—
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities7,0482,1953,501-8211,689
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash5,027-3,596-1,684506-732